IL6 and obesity disorder: Extending these observations to other settings of muscle wasting and elevated IL-6 and related cytokines, STAT3 activation might also mediate muscle loss in obesity [75], advanced age or sarcopenia [76], inflammatory myopathies [77], burn [78], and other diseases.